drugset / Trial / NCT02186483

Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin

NCT02186483 ↗

Phase 1 Completed 24 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetic drug interaction between Metformin and Rosuvastatin in healthy male volunteers.

Timeline

Start
2014-08
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —
Subject Rosuvastatin Small molecule 20 mg —